Cocrystal Pharma COCP
NASDAQ COCP
$1.17 +0.02 (+2.18%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) EBT Margin (2010 - 2026)

Cocrystal Pharma (COCP) posted EBT Margin of 1037.33% for Q1 2026, down 249.89% sequentially from 296.47% in Q4 2020.

Cocrystal Pharma (COCP) EBT Margin (2010 - 2026) Analysis & Trends

Cocrystal Pharma has reported EBT Margin for 8 years, with the latest figure at 1037.33% in Q1 2026.

  • Quarterly EBT Margin changed N/A year-over-year to 1037.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 525.31% (changed N/A YoY) and the FY2020 annual result came in at 479.05%, up 25479.0% from the prior year.
  • EBT Margin fell to 1037.33% in Q1 2026 per COCP's latest filing, from 296.47% in the prior quarter.
  • Over five years, EBT Margin peaked at 1037.33% in Q1 2026 and troughed at 1037.33% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 35.71%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.77%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -2.67%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -25.06%
10 Cocrystal Pharma 15.86 Mn 13.54 Mn - -3,022.86%

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,474.29%
Mar 31, 2026 -1,037.33%
Dec 31, 2020 -296.47%
Sep 30, 2020 -572.60%
Jun 30, 2020 -749.64%
Mar 31, 2020 -590.02%
Dec 31, 2019 -11,901.74%
Sep 30, 2019 -361.79%
Jun 30, 2019 -255.91%
Mar 31, 2019 58.51%
Sep 30, 2015 -2,116.67%
Jun 30, 2015 -9,522.22%
Mar 31, 2015 -108,618.52%
Jun 30, 2013 -37.31%
Mar 31, 2013 -72.74%
Dec 31, 2012 -79.17%
Sep 30, 2012 -2.50%
Jun 30, 2012 -14.54%
Mar 31, 2012 -103.87%
Dec 31, 2011 -50.25%